ANTI-TUMOR AGENT FOR MULTIPLE MYELOMA

摘要

Disclosed is a pharmaceutical composition which can exert its effect with higher efficiency on a living body having at least one cell selected from the group consisting of a cell that over-expresses FGFR3, a cell that has a t(4;14) translocation and a cell that expresses a mutant FGFR3. Also disclosed is a therapeutic method for the living body. A compound represented by the general formula (I) or a pharmaceutically acceptable salt thereof or a solvate of the compound or the salt can exert its effect with higher efficiency on a living body having at least one cell selected from the group consisting of a cell that over-expresses FGFR3, a cell that has a t(4;14) translocation and a cell that expresses a mutant FGFR3.